ArticleThe Journal of clinical investigation2018

TLR3 agonist and CD40-targeting vaccination induces immune responses and reduces HIV-1 reservoirs.

Liang Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.